Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Jun 29, 2021
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Reiterating Organization Eligibility and Application Submission for NIH Research Enhancement Awards (R15)
National Institutes of Health
General Notices
- Notice to Extend Eligibility for Submission to PAR-19-371, NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) due to COVID-related Disruptions
National Institute of Allergy and Infectious Diseases
- Notice of Pre-Application Webinar for the "Early Detection Research Network" Program: RFA-CA-21-033, RFA-CA-21-034, and RFA-CA-21-035
National Cancer Institute
- Notice of Pre-Application Webinar for Non-Human Primate Developmental Genotype-Tissue Expression Project (NHP dGTEx)
National Human Genome Research Institute
- NIH Announces the Open Period of FY 2022 Helium-3 Requests for Medical Research
National Heart, Lung, and Blood Institute
- Notice of Information: NIMH High-Priority Areas for Research on Women's Mental Health during the Perinatal Period
National Institute of Mental Health
- Request for Information (RFI): Inviting Input to Broaden the Benefits of AI/ML Technologies to Reduce Health Disparities and Inequities and Enhance the Diversity of the AI/ML Workforce
National Institutes of Health
Notice of Changes to Funding Opportunities
- Notice of Participation of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in PAR-20-125 Native American Research Centers for Health (NARCH) (S06 Clinical Trials Optional)
National Institute on Alcohol Abuse and Alcoholism
- Notice of Correction to the Response Date for NOT-CA-087 "Request for Information on Datasets Collecting Temporally-Linked Diet, Physical Activity, and Sleep Data to Facilitate Integrated Research on 24-Hour Behavior Patterns"
National Cancer Institute
- Notice of NIDCR Participation in RFA-CA-21-035 The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research
- Notice of NIDCR Participation in PAR-21-168, "Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)"
National Institute of Dental and Craniofacial Research
- Notice of Change to NOT-NR-19-011: "Notice of NINR's Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)"
National Institute of Nursing Research
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
National Cancer Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
National Cancer Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for the NIH HEAL Initiative: Preventing Opioid Misuse and other Drug Use by Intervening on Social Determinants (R01 Clinical Trials Optional)
National Institute on Drug Abuse
Office of Behavioral and Social Sciences Research
- Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Interdisciplinary Teams to Elucidate the Mechanisms of Device-Based Pain Relief (RM1 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
Notices of Special Interest
- Notice of Special Interest: Genetics of Alcohol Sensitivity and Tolerance
National Institute on Alcohol Abuse and Alcoholism
- Notice of Special Interest: Alzheimers-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimers Disease
National Institute on Aging
John E. Fogarty International Center
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
National Library of Medicine
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Notice of Special Interest (NOSI): Harnessing Big Data to Halt HIV
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Mental Health
- Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Mental Health
- Notice of Special Interest: Administrative Supplements for Cancer Moonshot awardees and Cancer Center Support Grants (CCSG) to Support Development of an "Immune Radiation Response Index (i-RRI)" for Immune Cells from Normal and Tumor Microenvironments
National Cancer Institute
- Notice of Special Interest (NOSI): New Information Technology-Enabled Care Delivery Models to Improve Depression Care in Cancer
National Cancer Institute
- Notice of Special Interest (NOSI): Advancing HIV/AIDS Research through Computational Neuroscience
National Institute on Drug Abuse
- Notice of Special Interest (NOSI): Navigating Pediatric to Adult Health Care: Lost in Transition
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
- Notice of Special Interest (NOSI): Clarification of the Objectives and Program Elements in NHGRI Applications Submitted in Response to the "Ruth L. Kirschstein NRSA Institutional Research Training Grants (Parent T32)"
National Human Genome Research Institute
Funding Opportunities
- Patient Safety Learning Laboratories: Advancing Patient Safety through Design, Systems Engineering, and Health Services Research (R18 Clinical Trial Optional)
Agency for Healthcare Research and Quality
- India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed)
National Eye Institute
- Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Optional)
National Institute on Alcohol Abuse and Alcoholism
- The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Institute on Aging
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
National Institute of Mental Health
Office of Research on Women's Health
- Data Enhancements and Analyses to Clarify the Relationship between Education and Cognitive Function (including AD/ADRD) (R01 Clinical Trial Not Allowed)
National Institute on Aging
- Program on the Origins of Gastroesophageal Cancers (R01 Clinical Trial Optional)
National Cancer Institute
- Coordinating Center for the Program on the Origins of Gastroesophageal Cancers (U24 Clinical Trial Not Allowed)
National Cancer Institute
- Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
National Cancer Institute
- Elucidating the Effects of ART on Neuronal Function in the Context of SUD and HIV (R01 - Clinical Trials Not Allowed)
National Institute on Drug Abuse
- Large Scale Mapping and/or Molecular Profiling of Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed)
National Institute on Drug Abuse
- NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional)
National Institute on Deafness and Other Communication Disorders
- Support for Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Allergy and Infectious Diseases
- CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)
National Institute of Environmental Health Sciences
National Eye Institute
National Institute of Allergy and Infectious Diseases
- Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R01 Clinical Trial Required)
National Institute of Mental Health
- Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R34 Clinical Trial Required)
National Institute of Mental Health
Office of Research on Women's Health
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek@uiowa.edu.